Breakthrough Pancreatic Cancer Therapy Sparks Clinic Rush After Doubling Survival Rates

Redwood City, Friday, 15 May 2026.
Surging demand for an experimental pancreatic cancer therapy follows clinical trials showing it doubled median patient survival to 13.2 months, marking a historic breakthrough for a highly lethal disease.